Centene Corp. stock closes at USD 69.16 near its daily high USD 71.06
Published on 10/17/2026 at 21:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPrice position and trading activity
- Centene Corp. finished 2.67 percent below its intraday high on October 16, 2026.
- Trading volume reached 3,336,075 shares against a 4,587,637-share average on October 16, 2026.
- Centene Corp. stock closed at USD 69.16 on October 16, 2026 at 4:00 p.m. ET, 2.88 percent below its 52-week high of USD 71.21.
- Centene's market capitalization was USD 34.2 billion on October 16, 2026.
Centene Corp. stock closed at USD 69.16 on October 16, 2026 at 4:00 p.m. ET, leaving the insurer 2.67 percent below its intraday high of USD 71.06. The closing level also stood 2.88 percent below the 52-week high of USD 71.21.
Trading activity stays below average
Centene traded 3,336,075 shares during the October 16 session, compared with an average volume of 4,587,637 shares. That puts turnover 27.28 percent below the average, a useful measure of how much conviction accompanied the session's price action.
The stock remained within its USD 31.63 to USD 71.21 52-week range on October 16, 2026. Its closing price was USD 37.53 above the yearly low and USD 2.05 below the yearly high.
Market value and peer comparison
Centene had a market capitalization of USD 34.2 billion on October 16, 2026. The company is listed on the NYSE under ticker CNC and operates in government-sponsored health coverage, including Medicaid, Medicare and Marketplace plans.
As of October 16, 2026, the comparison is:
Comparison with peers
Centene Corp. (NYSE, USD): minus 1.91 percent, market capitalization USD 34.2 billion
Humana (NYSE, USD): minus 4.37 percent, P/E 39.14, market capitalization USD 49.6 billion
Elevance Health (NYSE, USD): minus 0.04 percent, P/E 19.03, market capitalization USD 92.9 billion
What the range says
Centene's closing level was 2.88 percent below its 52-week high, while Humana's session decline was 2.46 percentage points steeper than Centene's. Elevance Health moved 1.87 percentage points better than Centene on the same date.
Centene's market value was USD 34.2 billion, below Humana's USD 49.6 billion and Elevance Health's USD 92.9 billion. The three stocks therefore showed different combinations of daily performance and scale within the managed-care group.
Centene stock stays near its yearly high
Centene's October 16 closing price of USD 69.16 was 2.88 percent below its 52-week high of USD 71.21, keeping the stock near the upper end of its annual range.
Market context: Market report S&P 500.
